4
Changes in Ownership
Immunovant, Inc. Filed Acc 0001764013-25-000160
Director sold 22,249 shares at an average $23.25 ($517,189)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Fromkin Andrew J. Director | 2025-12-01 | Sale 10b5-1 | −19,351 | $23.14 | $447,782 | 88,750 | D |
| Fromkin Andrew J. Director | 2025-12-01 | Sale 10b5-1 | −2,898 | $23.95 | $69,407 | 85,852 | D |
| Open-market sales · 22,249 sh · avg $23.25 · $517,189 | |||||||
Loading xslF345X05/wk-form4_1764803692.xml…